Overview

A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how SHP626 is absorbed and excreted from the body in healthy males.
Phase:
Phase 1
Details
Lead Sponsor:
Mirum Pharmaceuticals, Inc.
Shire
Treatments:
Volixibat